Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial

被引:0
|
作者
Shinya Fujiki
Atsushi Tanaka
Takumi Imai
Michio Shimabukuro
Hiroki Uehara
Ikuko Nakamura
Kazuo Matsunaga
Makoto Suzuki
Takeshi Kashimura
Tohru Minamino
Takayuki Inomata
Koichi Node
机构
[1] Niigata University Graduate School of Medical and Dental Sciences,Department of Cardiovascular Medicine
[2] Saga University,Department of Cardiovascular Medicine
[3] Osaka City University Graduate School of Medicine,Department of Medical Statistics
[4] Fukushima Medical University,Department of Diabetes, Endocrinology, and Metabolism
[5] Urasoe General Hospital,Division of Cardiology
[6] Saga-Ken Medical Centre Koseikan,Department of Cardiovascular Medicine
[7] Imari-Arita Kyoritsu Hospital,Department of Internal Medicine
[8] Yokohama Minami Kyosai Hospital,Department of Cardiology
[9] Juntendo University Graduate School of Medicine,Department of Cardiovascular Biology and Medicine
来源
Clinical Research in Cardiology | 2023年 / 112卷
关键词
Sodium–glucose cotransporter-2 (SGLT2) inhibitor; Canagliflozin; Estimated plasma volume (ePV); Estimated extracellular volume (eEV); Estimated glomerular filtration rate (eGFR); HFpEF; HFrEF;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:87 / 97
页数:10
相关论文
共 50 条
  • [32] Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post-hoc analysis of the PROCEED trial
    Maruhashi, Tatsuya
    Tanaka, Atsushi
    Takahashi, Kanae
    Higashi, Yukihito
    Node, Koichi
    DIABETES OBESITY & METABOLISM, 2024, 26 (05) : 1723 - 1730
  • [33] Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial
    Kusunose, Kenya
    Imai, Takumi
    Tanaka, Atsushi
    Dohi, Kaoru
    Shiina, Kazuki
    Yamada, Takahisa
    Kida, Keisuke
    Eguchi, Kazuo
    Teragawa, Hiroki
    Takeishi, Yasuchika
    Ohte, Nobuyuki
    Yamada, Hirotsugu
    Sata, Masataka
    Node, Koichi
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [34] Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial
    Kenya Kusunose
    Takumi Imai
    Atsushi Tanaka
    Kaoru Dohi
    Kazuki Shiina
    Takahisa Yamada
    Keisuke Kida
    Kazuo Eguchi
    Hiroki Teragawa
    Yasuchika Takeishi
    Nobuyuki Ohte
    Hirotsugu Yamada
    Masataka Sata
    Koichi Node
    Cardiovascular Diabetology, 20
  • [35] Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with a Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials
    Lou, Yake
    Yang, Qi
    Zhang, Weicong
    Yu, Ying
    Huang, Jing
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (11)
  • [36] Time-Varying Cardiovascular Outcomes of Sodium-Glucose Cotransporter Inhibitors in Patients With Type 2 Diabetes: A Post Hoc Analysis of Pivotal Trials Using Restricted Mean Survival Time
    Milioglou, Ioannis
    Motairek, Issam
    Deo, Salil
    Ramani, Ravi
    Neeland, Ian J.
    Rajagopalan, Sanjay
    Al-Kindi, Sadeer G.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (03):
  • [37] Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: A meta-analysis of placebo-controlled randomized trials
    Saad, Marwan
    Mahmoud, Ahmed N.
    Elgendy, Islam Y.
    Abuzaid, Ahmed
    Barakat, Amr F.
    Elgendy, Akram Y.
    Al-Ani, Mohammad
    Mentias, Amgad
    Nairooz, Ramez
    Bavry, Anthony A.
    Mukherjee, Debabrata
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 352 - 358
  • [38] Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post-hoc analysis from the WARCEF trial
    Corica, Bernadette
    Romiti, Giulio Francesco
    Simoni, Amalie Helme
    Mei, Davide Antonio
    Bucci, Tommaso
    Thompson, John L. P.
    Qian, Min
    Homma, Shunichi
    Proietti, Marco
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (05)
  • [39] Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial
    Takashima, Hiroyuki
    Yoshida, Yoshinori
    Nagura, Chinami
    Furukawa, Tetsuya
    Tei, Ritsukou
    Maruyama, Takashi
    Maruyama, Noriaki
    Abe, Masanori
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (05) : 469 - 472
  • [40] Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Zhou, Hufang
    Peng, Wenhua
    Li, Fuyao
    Wang, Yuelin
    Wang, Baofu
    Ding, Yukun
    Lin, Qian
    Zhao, Ying
    Pan, Guozhong
    Wang, Xian
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9